XRP Spot ETFs See Inflow Momentum Pause: Here's What the Numbers Tell Us

DEXRobinHood · 2026-01-05T14:56:57+00:00

XRP spot ETFs experienced a pause in positive capital movement on December 26, despite a significant cumulative capital injection of $1.14 billion. Trading activity remained strong, with daily volumes at $16.61 million, indicating ongoing investor engagement. Institutions continue to show strong interest, raising questions about future capital trends.

DEXRobinHood

2026-01-05 14:56:57

Abstract generation in progress

XRP spot ETFs hit a notable milestone on December 26—the first day without positive capital movement after a solid run of successive inflows. The pause doesn’t paint a bearish picture though. Cumulative capital injections have already surged to $1.14 billion, supporting a combined asset base valued at $1.24 billion across all XRP ETF offerings.

The Market Activity Behind the Pause

While yesterday saw flat inflow activity, the trading desks weren’t quiet. Daily volume clocked in at $16.61 million, suggesting investors remained engaged with these products. The broader XRP token itself continues to attract attention, trading around current levels in the $2.14 range based on recent market data.

Fund Performance Breakdown

The leadership in net assets tells an interesting story. XRPC Canary maintains its commanding position with $325.93 million under management. Not far behind, a roster of established names continues to build their XRP offerings—including 21Shares, Bitwise, Grayscale, and Franklin Templeton, each capturing meaningful portions of the growing ETF landscape for this asset.

What’s particularly notable: even with the inflow pause, the cumulative picture shows strong institutional appetite. Whether this represents consolidation before the next wave of capital or a temporary plateau remains a key question for market watchers.

XRP1%

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.